Key result
Neutrophil-derived netrin-1 attenuates myocardial ischemia-reperfusion injury via myeloid adenosine A2b receptor signaling.
Answers are grounded in this paper and cite their sources.
Previous studies implicated the neuronal guidance molecule netrin-1 in attenuating myocardial ischemia-reperfusion injury. However, the tissue-specific sources and receptor signaling events remain elusive. Neutrophils are among the first cells responding to an ischemic insult and can be associated with tissue injury or rescue. We found netrin-1 levels were elevated in the blood of patients with myocardial infarction, as well as in mice exposed to myocardial ischemia-reperfusion. Selectively increased infarct sizes and troponin levels were found in Ntn1loxP/loxP Lyz2 Cre+ mice, but not in mice with conditional netrin-1 deletion in other tissue compartments. In vivo studies using neutrophil depletion identified neutrophils as the main source for elevated blood netrin-1 during myocardial injury. Finally, pharmacologic studies using treatment with recombinant netrin-1 revealed a functional role for purinergic signaling events through the myeloid adenosine A2b receptor in mediating netrin-1-elicited cardioprotection. These findings suggest an autocrine signaling loop with a functional role for neutrophil-derived netrin-1 in attenuating myocardial ischemia-reperfusion injury through myeloid adenosine A2b signaling.
No takes yet. Share an insight, caveat, or question.
Li et al. (2021) studied Myocardial ischemia-reperfusion injury. Recombinant netrin-1 was evaluated on Infarct size and troponin levels. Neutrophil-derived netrin-1 attenuates myocardial ischemia-reperfusion injury through an autocrine signaling loop involving the myeloid adenosine A2b receptor.
Synapse has enriched 10 related papers. Consider them for comparative context: